Immunovant, Inc.
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fra…
Biotechnology
US, New York [HQ]
IMVT/Financial Reporting
Income Statements
6 Sheets · Starting from 2024In Million USD. Margins, Growth Rates In %
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Revenue | - - | - - | - - | - - | - - | - - | |
|
EPS
|
-1.29 | -1.54 | -1.22 | -1.43 | -1.71 | -1.88 | |
| Diluted in mil. | -1.29 | -1.54 | -1.22 | -1.43 | -1.71 | -1.88 | |
|
Profit
|
- - | - - | - - | -1.00 | -1.00 | - - | |
| Gross Margin | - - | - - | - - | - - | - - | - - | |
| Pre Tax | - - | -66.00 | -107.00 | -156.00 | -210.00 | -258.00 | |
| Profit Margin | - - | - - | - - | - - | - - | - - | |
| ETR | -0.07 | -0.15 | 0.33 | 0.05 | - - | -0.22 | |
| Net | - - | -66.00 | -107.00 | -156.00 | -210.00 | -259.00 | |
| Profit Margin | - - | - - | - - | - - | - - | - - | |
| EBITDA | - - | -65.00 | -107.00 | -156.00 | -198.00 | -269.00 | |
| EBITDA Margin | - - | - - | - - | - - | - - | - - | |
| Operating Income | - - | -65.00 | -107.00 | -156.00 | -198.00 | -270.00 | |
| Operating Margin | - - | - - | - - | - - | - - | - - | |
| Interest Income | - - | - - | - - | - - | 7.00 | -24.00 | |
| Loss | - - | -66.00 | -108.00 | -156.00 | -208.00 | -270.00 | |
| Cost of Revenue | - - | - - | - - | -1.00 | -1.00 | - - | |
|
Operating Expenses
|
- - | -66.00 | -108.00 | -156.00 | -208.00 | -269.00 | |
| R&D | - - | -47.00 | -68.00 | -101.00 | -160.00 | -212.00 | |
| G&A | - - | -18.00 | -39.00 | -54.00 | -48.00 | -57.00 | |
| SG&A | - - | -18.00 | -39.00 | -54.00 | -48.00 | -57.00 | |
| S&M | - - | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | - - | - - | - - | - - | - - | - - | |
| Interest Expenses | - - | - - | - - | - - | -12.00 | - - | |
| Other Expenses | - - | - - | - - | - - | -12.00 | -11.00 | |
|
WA Shares Outstanding
|
- - | 43.00 | 87.00 | 109.00 | 123.00 | 138.00 | |
| Diluted | - - | 43.00 | 87.00 | 109.00 | 123.00 | 138.00 |